Technology Landscape, Trends and Opportunities in the Global Stent Market
The technologies in stent have undergone significant change in recent years, with bare metal coronary stents to bioabsorbable stents. The rising wave of new technologies such as drug-eluting stents (DES) and bioabsorbable stents technology are creating significant potential for advanced stent implants in various medical platforms due to increasing adoption of minimally invasive techniques.
In stent market, various technologies such as drug-eluting stents (DES), bare-metal coronary stents, and bioabsorbable stents, iliac stents, femoral-popliteal stents, renal and related stents, and carotid stents are used in the coronary and peripheral vascular applications. Increasing adoption of minimally invasive techniques, rising number of cardiovascular surgeries, and hectic lifestyle coupled with rising geriatric population base are creating opportunities for various stent technologies.
This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the stent market. Some insights are depicted below by a sample figure. For more details on figures, the companies researched, and other objectives/benefits on this research report, please download the report brochure.
The study includes technology readiness, competitive intensity, regulatory compliance, disruption potential, trends, forecasts and strategic implications for the global stent technology by application, technology, and region as follows:
Technology Readiness by Technology Type
Competitive Intensity and Regulatory Compliance
Disruption Potential by Technology Type
Trends and Forecasts by Technology Type [$M shipment analysis from 2018 to 2030]:
- Drug-Eluting Stents (DES)
- Bare-Metal Coronary Stents
- Bioabsorbable Stents
- Iliac Stents
- Femoral-Popliteal Stents
- Renal and Related Stents
- Carotid Stents
Technology Trends and Forecasts by Application [$M shipment analysis from 2018 to 2030]:
- Coronary
- Drug-Eluting Stents (DES)
- Bare-Metal Coronary Stents
- Bioabsorbable Stents
- Peripheral Vascular
- Iliac Stents
- Femoral-Popliteal Stents
- Renal and Related Stents
- Carotid Stents
Technology Trends and Forecasts by Region [$M shipment analysis for 2018 – 2030]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- Germany
- France
- Asia Pacific
- Japan
- China
- South Korea
- India
- The Rest of the World
Latest Developments and Innovations in the Stent Technologies
Companies / Ecosystems
Strategic Opportunities by Technology Type
Some of the stent companies profiled in this report include Terumo Corporation, Stentys, Microport Scientific Corporation, Medtronic, Elixir Medical Corporation, C. R. Bard, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen, and Abbott Laboratories.
This report answers following 9 key questions:
Q.1 What are some of the most promising and high-growth technology opportunities for the stent market?
Q.2 Which technology will grow at a faster pace and why?
Q.3 What are the key factors affecting dynamics of different technologies? What are the drivers and challenges of these technologies in stent market?
Q.4 What are the levels of technology readiness, competitive intensity and regulatory compliance in this technology space?
Q.5 What are the business risks and threats to these technologies in stent market?
Q.6 What are the latest developments in stent technologies? Which companies are leading these developments?
Q.7 Which technologies have potential of disruption in this market?
Q.8 Who are the major players in this stent market? What strategic initiatives are being implemented by key players for business growth?
Q.9 What are strategic growth opportunities in this stent technology space?
Please note: It will take 2-3 business days to deliver the report upon receipt the order.